2822-50-6 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Nitro-4-(trifluoromethoxy)aniline is used as a building block for the synthesis of pharmaceuticals, leveraging its reactivity to create a variety of medicinal compounds. Its incorporation into drug molecules can enhance their efficacy and pharmacological properties.
Used in Agrochemical Production:
In the agrochemical industry, 3-Nitro-4-(trifluoromethoxy)aniline serves as a key intermediate in the production of various agrochemicals. Its unique structure allows for the development of compounds that can be used in crop protection and pest management.
Used in Dye and Pigment Manufacturing:
3-Nitro-4-(trifluoromethoxy)aniline is utilized in the manufacturing of dyes and pigments due to its ability to impart color. Its chemical structure contributes to the colorfastness and stability of the dyes and pigments produced, making it suitable for use in various applications, including textiles, plastics, and printing inks.
Used in Chemical Research:
3-NITRO-4-(TRIFLUOROMETHOXY)ANILINE is also used in chemical research for studying reactions and mechanisms involving substituted aniline derivatives. Its unique properties make it a valuable tool for understanding and developing new chemical processes and products.
It is crucial to handle and use 3-Nitro-4-(trifluoromethoxy)aniline with care, as it may pose health and environmental risks if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 2822-50-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,2 and 2 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2822-50:
(6*2)+(5*8)+(4*2)+(3*2)+(2*5)+(1*0)=76
76 % 10 = 6
So 2822-50-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H5F3N2O3/c8-7(9,10)15-6-2-1-4(11)3-5(6)12(13)14/h1-3H,11H2
2822-50-6Relevant academic research and scientific papers
Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
-
Example 1a, (2010/11/08)
The invention relates to novel products of formula (I): in which p = 0, 1 and 2; A = aryl, heteroaryl, carbocycle or heterocycle; X = single bond, -N(R6)-, -O-, -C(O)-, -S(O)n-, -N(R6)-C(O)-, -N(R6)-C(O)-N(R6')-, -N(R6)-C(S)-N(R6')-, -N(R6)-C(O)O-, -N(R6)
CARBONYL-AMINO SUBSTITUTED ACYL PHENYL UREA DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
-
Page/Page column 32, (2008/06/13)
The invention relates to compounds of formula (I) wherein the radicals have the cited meaning, in addition to the physiologically compatible salts thereof. The compounds, for example, can be used as medicaments for preventing and treating type 2 diabetes.
Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
-
Page 100, (2010/02/09)
The present invention relates to a cyclic urea compound of formula I: as defined herein. The invention is also directed to the process for its preparation, pharmaceutical composition comprising it and its pharmaceutical use, as an inhibitor on a protein kinase. Thus, it is useful for preventing or treating a physiological disorder capable of being modulated by inhibiting the activity of a protein kinase, such as a solid tumor.
